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Author an overall survival rate of about 7%(35). Significant mortality is due to a post-SCA 80 syndrome with severe cardiac and neurologic dysfunction that is related to impaired 81 metabolism and systemic inflammation(2, 19, 27). Failure of metabolic recovery results 82 in cardiac stunning, poor tissue perfusion and brain injury (27, 28, 49) . Serum 83 hyperglycemia and elevated lactate reflect a failed energetic recovery of critical 84 organs(3, 43). Associated with this metabolic dysfunction, an intense inflammation 85 described as a sepsis-like syndrome occurs with systemic pro-inflammatory cytokine 86
release(2). 87
Cooling after SCA can improve both heart function and neurologically intact 88 survival(25, 49). Our previous studies have shown that intra-ischemic cooling in heart 89 cells exposed to ischemia/reperfusion (I/R) and in mice cooled during cardiopulmonary 90 resuscitation (CPR) is highly protective and appears mediated via Akt, a pro-survival 91 kinase that has both metabolic and anti-inflammatory effects(5, 38). Furthermore, while 92 intra-CPR cooling may maximally protect heart and brain function it is difficult to achieve 93 clinically(25). Possible mechanisms of cooling protection include inhibition of 94 phosphatase and tensin homolog deleted on chromosomal 10 (PTEN), a ubiquitously 95 expressed and constitutively active phosphatase that converts PIP3 to PIP2 and 96 negatively regulates Akt activity (20) . 97
In support of a critical role for PTEN in I/R injury and protection, recent work by us 98 demonstrated that VO-OHpic (VO), a vanadyl small molecule compound that 99 demonstrates potent inhibition of PTEN(24, 36), induces cooling-like cardioprotection 100
with an almost 4-fold reduction in cell death and significant increase of p-Akt (48). To 101 extend these cell studies further, we studied whether VO could induce cooling-like 102 protection with improved recovery and survival in an established mouse model of SCA. were used for the survival study. After 2 h hemodynamic monitoring, mice were 128 disconnected from the ventilator. Once the mouse was determined to breathe on its own, 129 it was extubated and vascular access sites were surgically repaired. Mice were then 130 monitored for up to 72 h. 131 Cardiac Function. During the 2 h hemodynamic monitoring period, the cardiac 132 function was acquired and analyzed using PowerLab Chart (ADInstruments, Colorado 133 Springs, CO) and Millar PVAN 3.0 software (Millar Instruments, Houston, TX) as 134 previously described(5). Parameters, such as heart rate and left ventricular performance 135 indices including left ventricular maximum pressure (LVP max ), maximum rate of change 136 in the left ventricular pressure (dP/dt max ) were assessed using Millar Pressure-Volume 137
Conductance System. MAP was also measured in a separate set of mice using a 138 pressure catheter. In addition, CPR quality parameters were recorded, such as chest 139 compression rate (CC), partial pressure end-tidal CO 2 (P ETCO2 ) and time to achieve 140
ROSC. 141
Neurological Evaluation. Neurological function was evaluated at 6 h, 24 h and 72 h 142 following resuscitation (R6h, R24h and R72h) using an established scoring system that 143 includes level of consciousness, corneal reflex, respiration, righting reflex, coordination 144 and movement/activity ( Table 1 ). The neurological score was assigned according to the 145 prior studies (1, 11) . The scores range from 0 (death) to 12 (normal neurological 146 function). Tukey's test. Kaplan-Meier survival analysis was performed using log-rank (Mantel-Cox) 183 testing. T-test was used where applied. A value of p < 0.05 was considered statistically 184 significant. 185
186

RESULTS
187
PTEN Inhibitor VO-OHpic Improved Neurologically Intact Survival. Twenty mice 188
were randomized into NS and VO group (n = 10 each group). As depicted in Table 2, (Fig. 3A) , dP/dt max (Fig. 3B) , MAP (Fig. 3C ) and P ETCO2 (Fig. 3D) sham, cardiac p-Akt was decreased at R30 in the NS group and increased by VO at 208 p-Akt Thr308 (Fig. 4A, B) , p-Akt Ser473 (Fig. 4A, C) . Similar results were observed for 209 the Akt-related target p-GSK3β Ser9 (Fig. 4A, D) . In parallel studies, VO treatment also 210 increased both p-Akt and p-GSK3β in brain tissue (Fig. 4E-H) . 211
VO Increased Cardiac Phospholamban Phosphorylation. Heart tissue collected at 212
R30 was used to measure PLB phosphorylation, an additional Akt target and related to 213 contractile function and SERCA2α expression by Western blot. P-PLB was over 4-fold 214 higher in VO group compared to NS group (Fig. 5A, B) . The SERCA2α expression was 215 not changed by VO treatment (Fig. 5A, C) . 216
VO Treatment Enhanced Cardiac Energetic Recovery (PCr:ATP).
The 31 P NMR 217 spectrum in Fig. 6A illustrates the relative levels of phosphocreatine (PCr) and ATP in an 218 isolated, perfused sham heart. The PCr:ATP ratio serves as an index of the intracellular 219 bioenergetic state (15, 18, 34). The ratio for the sham group was 1.7 (Fig. 6B) , in 220 agreement with previously published data(29). The ratio was significantly reduced in the 221 NS group (1.5). The reduced PCr recovery relative to ATP content is indicative of a low 222 intracellular phosphorylation potential and impaired mitochondrial recovery. In the VO 223 group, the ratio of PCr:ATP (1.8) was significantly greater than the NS and not 224 significantly different from the shams. Intracellular organic phosphate was not discernible 225 in 31 P NMR spectra at 2 h, thereby precluding evaluation of intracellular pH based on the 226 resonant position of P i . 227
Active PDH. Pyruvate dehydrogenase (PDH) is a rate-limiting enzyme of pyruvate 228 dehydrogenase complex. P-PDH at R30 in NS-and VO-treated heart tissues were 229 analyzed and demonstrated a decrease by VO (Fig. 6C) suggesting improved pyruvate 230 oxidation and glucose utilization. 231
VO Attenuated Plasma Lactate and Glucose and Modulated Mediators of 232
Inflammation. VO attenuated plasma lactate levels at both R30 and R2h compared to NS 233 (Fig. 7A) . Plasma glucose was also reduced by VO at R4h (Fig. 7B) . A panel of cytokines 234 including IL-6, KC, TNFα, INF-γ, IL-1β and IL-10 were noticed to elevate significantly, 235 consistent with the "cytokine storm" reported after human SCA(2). VO treatment most 236 affected IL-1β and IL-10. IL-1β, a pro-inflammatory cytokine, was elevated almost 2-fold 237 at R4h and was attenuated by VO. In contrast, IL-10, an anti-inflammatory cytokines, 238 was marked increased by VO (Fig. 8A, B) . In addition, we assessed PBEF, an 239 adipokine/pro-inflammatory cytokine that has been recently associated with 240 decompensated heart failure(37), diabetes type II(7), and hemorrhagic shock(4). 241
Compared to sham, plasma PBEF levels were rapidly increased as early as R30 and 242 continued to increase upwards of 20-fold by R4h. VO attenuated PBEF levels at both 243 time points (Fig. 8C ). Other cytokines were not affected by VO treatment (Fig. 8D-G) . 244
245
DISCUSSION 246
The present study builds upon prior laboratory work suggesting that cooling 247 protection after SCA may be mediated by PTEN inhibition and enhanced Akt signaling, 248 and in heart cells can be reproduced without cooling using PTEN inhibition strategies 249 (48). The present study intended to study the effect of early signaling of Akt on cardiac 250 function and survival given the fact that in human studies, early recovery of MAP within 251 hours of resuscitation correlates with improved survival and better neurological 252 outcomes due to better tissue perfusion (9, 33). While a few studies have reported 253 vanadium small molecule PTEN inhibitor protection in acute myocardial infarction and 254 acute stroke models, the present study for the first time extends this prior work to the 255 systemic ischemia/reperfusion injury of sudden cardiac arrest. Optimal VO 256 administration given prior to mouse SCA significantly increased Akt activation in both 257 heart and brain as measured by p-Akt and phosphorylation of two Akt targets GSK3β 258 and phospholamban (Figs. 4, 5) . Compared to NS, VO increased overall metabolic 259 recovery after SCA as measured by decreased plasma lactate and glucose 260 concentrations (Fig. 7) . VO also decreased systemic inflammation as measured by 261 increased anti-inflammatory cytokine plasma concentrations (i.e. IL-10) along with 262 reduced pro-inflammatory cytokines (i.e. IL-1β and PBEF) within 4 h after CPR (Fig. 8) . 263 VO reduced cardiac performance deterioration as measured by LVP max and dP/dt max 264 within 2 h after CPR (Fig. 3) , and improved heart energetics assessed by PCr:ATP and 265 glucose oxidation measured by p-PDH (Fig. 6) . In addition to early cardiovascular 266 recovery, VO results in improved 72 h neurologically intact survival (Fig. 1) . 267
268
PTEN Inhibition and Optimal Akt Activation after SCA. Previous studies show that 269
cooling protection against ischemia/reperfusion (I/R) in both heart and brain is mediated 270 by Akt signaling(5, 38, 46, 47). Intra-CPR cooling appears highly protective in animal 271 models against the injury of sudden cardiac arrest (1, 44) and its protection abrogated by 272 partial Akt deletion (5). Given that intra-CPR cooling is technically difficult to achieve 273 clinically to improved human SCA survival (Fig. 5, 6)(3, 43) . It also identifies additional 285 targets that may relate to SCA recovery, such as enhanced phosphorylation of 286 phospholamban (Fig. 5) that is phosphorylated by Akt at its Thr17 site (41) and increases 287 cardiac contractility. 288
289
Energetic Recovery with VO Treatment. The additional novelty of the current study is 290 that the ischemic insult and resuscitation were performed, in vivo, two hours prior to 291 excising the mouse heart to access energetic recovery. This adds a far greater level of 292 physiological sophistication by integrating whole body effects of SCA on cardiac 293 recovery. Fig. 6A, B shows that the energetic recovery (PCr:ATP) from SCA is 294 significantly improved with VO treatment compared to non-treated NS group. Relative to 295 the sham group, the treated group reveals complete energetic recovery. In fact, the trend 296 for the treated group suggests a modest (non-significant) "overshoot". This finding 297
indicates the VO treatment attenuates mitochondria impairment upon reperfusion. 298
Because baseline measures of PCr and ATP where not measured prior to the SCA 299 event, in vivo, PCr and ATP signal for the isolated-perfused sham hearts are used as a 300 relative index of baseline content for all isolated-perfused hearts. The NS group shows 301 both a reduced ATP and PCr pool relative to shams. The PCr pool for the VO treated 302 hearts is modestly greater than the sham group, while ATP was slightly reduced in two of 303 the five hearts (non significant). Therefore, the "overshoot" is accounted for by both the 304 modest increased in PCr or loss in ATP (non-significant). 305
In addition, VO decreased PDH phosphorylation, demonstrating a significant 306 increase in the amount of PDH in the active form (Fig. 6C ). This would be consistent with 307 increased activity through the enzyme, and suggest increased pyruvate oxidation and 308 glucose utilization. These consequences may be the results of increased glucose uptake 309 by Glut 4 and upregulated PDH activity by GSK3β and FOXO-1 that was regulated by 310
Akt activation (12, 13, 16, 21, 45) to improve glycolysis and mitochondrial oxidation. Further, upregulated plasma cytokines associated with enhanced metabolic recovery 330 observed in the present study suggests that improved glycolysis and glucose oxidation 331 provides energy, such as ATP, required for immune cells, including neutrophils, to 332 augment the immune responses (6). Of note, the observation that resuscitation within 4h 333 did not decrease the plasma concentration of IL-1β and PBEF which were reduced by 334 VO indicating regulation of these two cytokines are related to PTEN inhibition by VO. In 335 contrast, IL-10 was increased by both reperfusion and VO suggesting that a 336 consequence of both reduced organ damage and PTEN effect may be involved. 337 I/R injury, like SCA, causes accumulation of osmotic metabolites and (such as 338 lactate and ions) due to impaired glucose oxidation resulting in drop of pH, acidosis and 339 increase lactate concentrations in blood, ultimately leading to dysregulation of 340 mechanical contraction and ionic homeostasis imbalance. 341
The current study has limitations. We used pretreatment of VO (prior to SCA) to 342 ensure optimal Akt activation in heart and brain within minutes after CPR as reported. in an isolated retrograde perfused sham heart. The ratio of the area for the PCr 598 resonance relative to the ATP is used here as a measure of the energetic reserve. B: 599
Relative to the shams (n = 4), the NS group (n = 5) showed an expected drop in 600 energetic reserve 2h after reperfusion ( # p < 0.05). VO group (n = 5) recovered energetic 601 reserve ( # p < 0.05). Data presented are means ± SEM. Pi ext , inorganic phosphate signal 602 from extracellular buffer; PCr, phosphocreatine; ATP, adenosine triphosphate groups. C: 603 p-PDH E1 alpha Ser293 at R30 in heart was analyzed by Western blot and shows an 604
